Pure Biologics S.A. (PUR.WA)
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
2.17+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-67.4%
The outlook
Pure Biologics S.A. currently reads as leaning bearish based on mixed vs its moving averages, 12% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range12% of the way from its 52-week low to high
Market cap
$26.6M
52-wk high
8.11
52-wk low
1.35
50-day avg
2.16
200-day avg
3.23
Trailing P/E
—